INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Boston University
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Boston University (8)
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
A role for the circadian transcription factor NPAS2 in the progressive loss of non-rapid eye movement sleep and increased arousal during fentanyl withdrawal in male mice
Psychopharmacology, Vol. 239, Núm. 10, pp. 3185-3200
-
Blueberry juice augments exercise-induced neuroprotection in a Parkinson's disease model through modulation of GDNF levels
IBRO Neuroscience Reports, Vol. 12, pp. 217-227
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477